Synthesis of a model trisaccharide for studying the interplay between the anti α-Gal antibody and the trans-sialidase reactions in Trypanosoma cruzi

Trypanosoma cruzi, the etiologic agent of Chagas disease, is covered by a dense glycocalix mainly composed by glycoproteins called mucins which are also the acceptors of sialic acid in a reaction catalyzed by a trans-sialidase (TcTS). Sialylation of trypomastigote mucins protects the parasite from l...

Descripción completa

Detalles Bibliográficos
Publicado: 2017
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00086215_v450_n_p30_Giorgi
http://hdl.handle.net/20.500.12110/paper_00086215_v450_n_p30_Giorgi
Aporte de:
id paper:paper_00086215_v450_n_p30_Giorgi
record_format dspace
spelling paper:paper_00086215_v450_n_p30_Giorgi2023-06-08T14:33:06Z Synthesis of a model trisaccharide for studying the interplay between the anti α-Gal antibody and the trans-sialidase reactions in Trypanosoma cruzi Anti α-gal Trans-sialidase Trypanosoma cruzi Carboxylic acids Biochemical studies Etiologic agents Infection process Reaction catalyzed Synthetic approach Trans-sialidases Trypanosoma cruzi Virulent strains Antibodies 6 aminohexyl glycoside glycoside sialidase trisaccharide unclassified drug antibody calcium binding protein galactose-binding protein glucose transporter glycoprotein periplasmic binding protein sialidase trans-sialidase trisaccharide Article biochemical analysis carbohydrate synthesis conjugation nonhuman priority journal sialylation Trypanosoma cruzi carbohydrate analysis chemistry immunology metabolism synthesis Trypanosoma cruzi Antibodies Calcium-Binding Proteins Carbohydrate Sequence Chemistry Techniques, Synthetic Glycoproteins Monosaccharide Transport Proteins Neuraminidase Periplasmic Binding Proteins Trisaccharides Trypanosoma cruzi Trypanosoma cruzi, the etiologic agent of Chagas disease, is covered by a dense glycocalix mainly composed by glycoproteins called mucins which are also the acceptors of sialic acid in a reaction catalyzed by a trans-sialidase (TcTS). Sialylation of trypomastigote mucins protects the parasite from lysis by the anti α-Galp antibodies from serum. The TcTS is essential for the infection process since T. cruzi is unable to biosynthesize sialic acid. The enzyme specifically transfers it from a terminal β-D-Galp unit in the host glycoconjugate to terminal β-D-Galp units in the parasite mucins to construct the D-NeuNAc(α2→3)β-D-Galp motif. On the other hand, although galactose is the most abundant sugar in mucins of both, the infective trypomastigotes and the insect stage epimastigotes, α-D-Galp is only present in the infective stage whereas β-D-Galf is characteristic of the epimastigote stage of the less virulent strains. Neither α-D-Galp nor D-Galf is acceptor of sialic acid. In the mucins, some of the oligosaccharides are branched with terminal β-D-Galp units to be able to accept sialic acid in the TcTS reaction. Based on previous reports showing that anti α-Galp antibodies only partially colocalize with sialic acid, we have undertaken the synthesis of the trisaccharide α-D-Galp(1→3)-[β-D-Galp(1→6)]-D-Galp, the smallest structure containing both, the antigenic D-Galp(α1→3)-D-Galp unit and the sialic acid-acceptor β-D-Galp unit. The trisaccharide was obtained as the 6-aminohexyl glycoside to facilitate further conjugation for biochemical studies. The synthetic approach involved the α-galactosylation at O-4 of a suitable precursor of the reducing end, followed by β-galactosylation at O-6 of the same precursor and introduction of the 6-aminohexyl aglycone. The fully deprotected trisaccharide was successfully sialylated by TcTS using either 3′-sialyllactose or fetuin as donors. The product, 6-aminohexyl α-D-NeuNAc(2→3)-β-D-Galp(1→6)-[α-D-Galp(1→3)]-β-D-Galp, was purified and characterized. © 2017 Elsevier Ltd 2017 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00086215_v450_n_p30_Giorgi http://hdl.handle.net/20.500.12110/paper_00086215_v450_n_p30_Giorgi
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Anti α-gal
Trans-sialidase
Trypanosoma cruzi
Carboxylic acids
Biochemical studies
Etiologic agents
Infection process
Reaction catalyzed
Synthetic approach
Trans-sialidases
Trypanosoma cruzi
Virulent strains
Antibodies
6 aminohexyl glycoside
glycoside
sialidase
trisaccharide
unclassified drug
antibody
calcium binding protein
galactose-binding protein
glucose transporter
glycoprotein
periplasmic binding protein
sialidase
trans-sialidase
trisaccharide
Article
biochemical analysis
carbohydrate synthesis
conjugation
nonhuman
priority journal
sialylation
Trypanosoma cruzi
carbohydrate analysis
chemistry
immunology
metabolism
synthesis
Trypanosoma cruzi
Antibodies
Calcium-Binding Proteins
Carbohydrate Sequence
Chemistry Techniques, Synthetic
Glycoproteins
Monosaccharide Transport Proteins
Neuraminidase
Periplasmic Binding Proteins
Trisaccharides
Trypanosoma cruzi
spellingShingle Anti α-gal
Trans-sialidase
Trypanosoma cruzi
Carboxylic acids
Biochemical studies
Etiologic agents
Infection process
Reaction catalyzed
Synthetic approach
Trans-sialidases
Trypanosoma cruzi
Virulent strains
Antibodies
6 aminohexyl glycoside
glycoside
sialidase
trisaccharide
unclassified drug
antibody
calcium binding protein
galactose-binding protein
glucose transporter
glycoprotein
periplasmic binding protein
sialidase
trans-sialidase
trisaccharide
Article
biochemical analysis
carbohydrate synthesis
conjugation
nonhuman
priority journal
sialylation
Trypanosoma cruzi
carbohydrate analysis
chemistry
immunology
metabolism
synthesis
Trypanosoma cruzi
Antibodies
Calcium-Binding Proteins
Carbohydrate Sequence
Chemistry Techniques, Synthetic
Glycoproteins
Monosaccharide Transport Proteins
Neuraminidase
Periplasmic Binding Proteins
Trisaccharides
Trypanosoma cruzi
Synthesis of a model trisaccharide for studying the interplay between the anti α-Gal antibody and the trans-sialidase reactions in Trypanosoma cruzi
topic_facet Anti α-gal
Trans-sialidase
Trypanosoma cruzi
Carboxylic acids
Biochemical studies
Etiologic agents
Infection process
Reaction catalyzed
Synthetic approach
Trans-sialidases
Trypanosoma cruzi
Virulent strains
Antibodies
6 aminohexyl glycoside
glycoside
sialidase
trisaccharide
unclassified drug
antibody
calcium binding protein
galactose-binding protein
glucose transporter
glycoprotein
periplasmic binding protein
sialidase
trans-sialidase
trisaccharide
Article
biochemical analysis
carbohydrate synthesis
conjugation
nonhuman
priority journal
sialylation
Trypanosoma cruzi
carbohydrate analysis
chemistry
immunology
metabolism
synthesis
Trypanosoma cruzi
Antibodies
Calcium-Binding Proteins
Carbohydrate Sequence
Chemistry Techniques, Synthetic
Glycoproteins
Monosaccharide Transport Proteins
Neuraminidase
Periplasmic Binding Proteins
Trisaccharides
Trypanosoma cruzi
description Trypanosoma cruzi, the etiologic agent of Chagas disease, is covered by a dense glycocalix mainly composed by glycoproteins called mucins which are also the acceptors of sialic acid in a reaction catalyzed by a trans-sialidase (TcTS). Sialylation of trypomastigote mucins protects the parasite from lysis by the anti α-Galp antibodies from serum. The TcTS is essential for the infection process since T. cruzi is unable to biosynthesize sialic acid. The enzyme specifically transfers it from a terminal β-D-Galp unit in the host glycoconjugate to terminal β-D-Galp units in the parasite mucins to construct the D-NeuNAc(α2→3)β-D-Galp motif. On the other hand, although galactose is the most abundant sugar in mucins of both, the infective trypomastigotes and the insect stage epimastigotes, α-D-Galp is only present in the infective stage whereas β-D-Galf is characteristic of the epimastigote stage of the less virulent strains. Neither α-D-Galp nor D-Galf is acceptor of sialic acid. In the mucins, some of the oligosaccharides are branched with terminal β-D-Galp units to be able to accept sialic acid in the TcTS reaction. Based on previous reports showing that anti α-Galp antibodies only partially colocalize with sialic acid, we have undertaken the synthesis of the trisaccharide α-D-Galp(1→3)-[β-D-Galp(1→6)]-D-Galp, the smallest structure containing both, the antigenic D-Galp(α1→3)-D-Galp unit and the sialic acid-acceptor β-D-Galp unit. The trisaccharide was obtained as the 6-aminohexyl glycoside to facilitate further conjugation for biochemical studies. The synthetic approach involved the α-galactosylation at O-4 of a suitable precursor of the reducing end, followed by β-galactosylation at O-6 of the same precursor and introduction of the 6-aminohexyl aglycone. The fully deprotected trisaccharide was successfully sialylated by TcTS using either 3′-sialyllactose or fetuin as donors. The product, 6-aminohexyl α-D-NeuNAc(2→3)-β-D-Galp(1→6)-[α-D-Galp(1→3)]-β-D-Galp, was purified and characterized. © 2017 Elsevier Ltd
title Synthesis of a model trisaccharide for studying the interplay between the anti α-Gal antibody and the trans-sialidase reactions in Trypanosoma cruzi
title_short Synthesis of a model trisaccharide for studying the interplay between the anti α-Gal antibody and the trans-sialidase reactions in Trypanosoma cruzi
title_full Synthesis of a model trisaccharide for studying the interplay between the anti α-Gal antibody and the trans-sialidase reactions in Trypanosoma cruzi
title_fullStr Synthesis of a model trisaccharide for studying the interplay between the anti α-Gal antibody and the trans-sialidase reactions in Trypanosoma cruzi
title_full_unstemmed Synthesis of a model trisaccharide for studying the interplay between the anti α-Gal antibody and the trans-sialidase reactions in Trypanosoma cruzi
title_sort synthesis of a model trisaccharide for studying the interplay between the anti α-gal antibody and the trans-sialidase reactions in trypanosoma cruzi
publishDate 2017
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00086215_v450_n_p30_Giorgi
http://hdl.handle.net/20.500.12110/paper_00086215_v450_n_p30_Giorgi
_version_ 1768543928191025152